What’s in a name? Moderna’s “vaccine” vs. “therapy” dilemma
Is it the Department of Defense or the Department of War? The Gulf of Mexico or the Gulf of America? A vaccine—or an “individualized neoantigen treatment”? That’s the Trump-era vocabulary paradox facing Moderna, the covid-19 shot maker whose plans for next-generation mRNA vaccines against flus and emerging pathogens have been dashed by vaccine skeptics in…
Community read
How readers judge the impact of this story. Pick the option that matches your own read — Beneficial, Harmful, or Uncertain are peer choices, not a default.
Beneficial
0
Harmful
0
Uncertain
0
Average sentiment
No votes yet
Based on beneficial vs harmful votes across the current response set. Uncertain votes are shown separately and do not shift the average.
Your read
Archive actions
Save this article to your personal archive for later review without turning the product into a visible popularity contest.